Cargando…
Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol
INTRODUCTION: The mainstay of leprosy treatment is multidrug treatment (MDT), which contains rifampicin, dapsone and clofazimine. The occurrence of dapsone hypersensitivity syndrome (DHS), a sudden, potentially fatal and traumatic adverse reaction due to dapsone, may affect treatment adherence and m...
Autores principales: | Krismawati, Hana, Ferdiana, Astri, Irwanto, Astrid, Budiawan, Teky, Imaniar, Clara, Wahyuni, Tri, Singh, Pushpendra, Mieras, Liesbeth, Pongtiku, Arry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096541/ https://www.ncbi.nlm.nih.gov/pubmed/35545382 http://dx.doi.org/10.1136/bmjopen-2021-057173 |
Ejemplares similares
-
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
por: Krismawati, Hana, et al.
Publicado: (2020) -
The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis
por: Schoenmakers, Anne, et al.
Publicado: (2020) -
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia
por: Maladan, Yustinus, et al.
Publicado: (2021) -
The unbreakable journey: using photovoice to raise awareness and fight leprosy stigma in Papua, Indonesia
por: Dien, Ragil, et al.
Publicado: (2023) -
A new Mycobacterium leprae dihydropteroate synthase variant (V39I) from Papua, Indonesia
por: Maladan, Yustinus, et al.
Publicado: (2019)